Pioneer Investment Management Has Lifted Expeditors International O (EXPD) Holding, Cara Therapeutics (CARA) Shorts Up By 6.41%

June 19, 2017 - By Maria Brooks

Pioneer Investment Management Inc increased Expeditors International O (EXPD) stake by 18.56% reported in 2016Q4 SEC filing. Pioneer Investment Management Inc acquired 67,658 shares as Expeditors International O (EXPD)’s stock declined 6.64%. The Pioneer Investment Management Inc holds 432,244 shares with $22.89M value, up from 364,586 last quarter. Expeditors International O now has $10.15B valuation. The stock declined 0.82% or $0.47 reaching $56.55 on the news. About 350,581 shares traded. Expeditors International of Washington (NASDAQ:EXPD) has risen 10.45% since June 19, 2016 and is uptrending. It has underperformed by 6.25% the S&P500.

Cara Therapeutics Incorporated (NASDAQ:CARA) had an increase of 6.41% in short interest. CARA’s SI was 7.16 million shares in June as released by FINRA. Its up 6.41% from 6.73M shares previously. With 1.53M avg volume, 5 days are for Cara Therapeutics Incorporated (NASDAQ:CARA)’s short sellers to cover CARA’s short positions. The SI to Cara Therapeutics Incorporated’s float is 31.33%. About 347,780 shares traded. Cara Therapeutics Inc (NASDAQ:CARA) has risen 206.00% since June 19, 2016 and is uptrending. It has outperformed by 189.30% the S&P500.

Since February 22, 2017, it had 0 buys, and 7 sales for $4.17 million activity. $72,134 worth of Expeditors International of Washington (NASDAQ:EXPD) was sold by McClincy Christopher J.. The insider MALONE MICHAEL J sold 7,000 shares worth $393,568. Shares for $233,669 were sold by COUGHLIN PHILIP M. $231,035 worth of Expeditors International of Washington (NASDAQ:EXPD) shares were sold by Musser Jeffrey S. 32,000 Expeditors International of Washington (NASDAQ:EXPD) shares with value of $1.80 million were sold by KOURKOUMELIS DAN. ALGER EUGENE K also sold $210,188 worth of Expeditors International of Washington (NASDAQ:EXPD) shares.

Among 12 analysts covering Expeditors International of Washington (NASDAQ:EXPD), 3 have Buy rating, 2 Sell and 7 Hold. Therefore 25% are positive. Expeditors International of Washington had 24 analyst reports since August 11, 2015 according to SRatingsIntel. Buckingham Research initiated Expeditors International of Washington (NASDAQ:EXPD) on Tuesday, December 15 with “Neutral” rating. The stock has “Positive” rating by Susquehanna on Tuesday, August 11. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, August 4. The stock of Expeditors International of Washington (NASDAQ:EXPD) earned “Market Perform” rating by Cowen & Co on Friday, March 18. Macquarie Research maintained Expeditors International of Washington (NASDAQ:EXPD) rating on Wednesday, November 4. Macquarie Research has “Neutral” rating and $52 target. The stock of Expeditors International of Washington (NASDAQ:EXPD) has “Hold” rating given on Wednesday, August 19 by Evercore. Zacks downgraded the shares of EXPD in report on Monday, August 31 to “Buy” rating. The firm has “Neutral” rating by UBS given on Friday, October 9. The firm earned “Buy” rating on Tuesday, September 22 by S&P Research. The rating was downgraded by UBS on Thursday, January 7 to “Sell”.

Pioneer Investment Management Inc decreased Allegheny Technologies Inc (NYSE:ATI) stake by 46,678 shares to 224,671 valued at $3.58M in 2016Q4. It also reduced Cognizant Technology Solut (NASDAQ:CTSH) stake by 196,935 shares and now owns 5.03M shares. Alder Biopharmaceuticals I (NASDAQ:ALDR) was reduced too.

Investors sentiment increased to 0.99 in 2016 Q4. Its up 0.21, from 0.78 in 2016Q3. It improved, as 40 investors sold EXPD shares while 173 reduced holdings. 61 funds opened positions while 149 raised stakes. 163.12 million shares or 3.10% more from 158.21 million shares in 2016Q3 were reported. Gateway Advisers Lc reported 12,592 shares. Louisiana-based Diversified Inv Strategies Limited has invested 1.22% in Expeditors International of Washington (NASDAQ:EXPD). Bokf Na has invested 0.06% in Expeditors International of Washington (NASDAQ:EXPD). First Financial Corp In accumulated 0.02% or 530 shares. Quantbot Techs Lp accumulated 37,535 shares or 0.22% of the stock. Deutsche Comml Bank Ag has invested 0.03% in Expeditors International of Washington (NASDAQ:EXPD). Thrivent Financial For Lutherans holds 0% or 6,270 shares in its portfolio. Marshfield owns 1.26M shares. Financial Bank Of Nova Scotia reported 3,971 shares. Trust Of Vermont holds 0.04% or 6,455 shares. Commonwealth Retail Bank Of Aus stated it has 1.86% of its portfolio in Expeditors International of Washington (NASDAQ:EXPD). Hanson & Doremus Mgmt reported 0% in Expeditors International of Washington (NASDAQ:EXPD). Pnc Financial Serv Incorporated reported 27,048 shares. Ameritas Investment Ptnrs invested 0.03% of its portfolio in Expeditors International of Washington (NASDAQ:EXPD). Guardian Life Insur Of America reported 691 shares stake.

Investors sentiment decreased to 1.26 in 2016 Q4. Its down 0.57, from 1.83 in 2016Q3. It fall, as 12 investors sold Cara Therapeutics Inc shares while 23 reduced holdings. 18 funds opened positions while 26 raised stakes. 12.12 million shares or 4.42% more from 11.60 million shares in 2016Q3 were reported. Northern Trust Corporation holds 230,727 shares. Fmr Ltd Llc reported 90,999 shares. Deutsche Natl Bank Ag, a Germany-based fund reported 24,499 shares. Prelude Capital Management Lc holds 18,521 shares or 0.02% of its portfolio. Geode Ltd Limited Liability Company reported 177,313 shares. Moreover, Cambridge Research has 0% invested in Cara Therapeutics Inc (NASDAQ:CARA) for 11,764 shares. Rho Cap Ptnrs reported 3.07M shares or 21.84% of all its holdings. D E Shaw holds 39,340 shares. Cam Group Incorporated Hldg A S holds 0.06% of its portfolio in Cara Therapeutics Inc (NASDAQ:CARA) for 319,820 shares. 11,647 are held by Citadel Advisors Ltd Liability Company. Eam Investors Ltd Liability stated it has 0.3% in Cara Therapeutics Inc (NASDAQ:CARA). Alphamark Advsrs Ltd Liability stated it has 0.01% of its portfolio in Cara Therapeutics Inc (NASDAQ:CARA). Grt Prtnrs Ltd Com owns 87,379 shares. Magee Thomson Inv Ltd Limited Liability Company invested in 114 shares. Blackrock Inc has invested 0% in Cara Therapeutics Inc (NASDAQ:CARA).

Since March 31, 2017, it had 1 buying transaction, and 0 insider sales for $9.10 million activity. RHO Ventures VI LP bought $9.10 million worth of stock.

Among 5 analysts covering Cara Therapeutics (NASDAQ:CARA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cara Therapeutics had 7 analyst reports since July 27, 2015 according to SRatingsIntel. Needham maintained the shares of CARA in report on Friday, July 24 with “Buy” rating. As per Thursday, November 24, the company rating was maintained by Scotia Capital. H.C. Wainwright initiated the shares of CARA in report on Thursday, October 13 with “Buy” rating. The firm earned “Buy” rating on Wednesday, November 4 by Cantor Fitzgerald.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: